Source: International Congress 2019 – Advances in clinical management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Brat (Brno, Czech Republic), M. Plutinsky (Brno, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), E. Volakova (Olomouc, Czech Republic), M. Svoboda (Brno, Czech Republic), M. Skrobackova (Brno, Czech Republic), P. Popelkova (Ostrava, Czech Republic), B. Novotna (Prague, Czech Republic), V. Koblizek (Hradec Kralove, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), O. Kudela (Hradec Kralove, Czech Republic), P. Musilova (Jihlava, Czech Republic), K. Neumannova (Olomouc, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), P. Vanik (Ceske Budejovice, Czech Republic), M. Spruit (Maastricht, Netherlands), F. Franssen (Horn, Netherlands), L. Vanfleteren (Gothenburg, Sweden). Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.. 3892

Member's Comments

No comment yet.

Related content which might interest you: Validation of bode index as a predictor of mortality in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 The new prognostic multidimensional index HODEH in patient with COPD Source: Annual Congress 2008 - Prognosis in COPD Year: 2008 Is it possible to improve the prediction ability of the BODE index? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014 COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 The index distance-saturation product like predicting of mortality in patients with COPD Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment Year: 2008 Validated the power of terminal status criteria in the prediction of 1-year mortality in patiens with COPD Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Mortality risk prediction in COPD by a prognostic biomarker panel Source: Eur Respir J 2014; 44: 1557-1570 Year: 2014 Prognostic usefulness of severity scales for the initial assessment of elderly people with a diagnosis of pneumonia due to COVID-19. Design of a multivariate predictive model of mortality. Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021 The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 An innovative risk score for prediction of asthma related adverse outcome Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis. Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Clinical phenotyping of COPD patients: a simple tool with prognosis value Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Prediction of one or two years’ exacerbation free time in primary care COPD patients, a validated prediction nomogram Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD Year: 2017 FEV1/Height2 could be a better alternative than FEV1 in predicting all cause mortality in patients with COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 An RDW-based score predicts mid-term mortality in patients hospitalized with community acquired pneumonia (CAP): a derivation and validation study Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Clinical prognostic tools and their use in COPD. Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 281-282 Year: 2016 Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Source: Eur Respir J 2016; 48: 279-281 Year: 2016